These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26640461)

  • 1. Editorial: Why Vaccines to HIV, HCV, and Malaria Have So Far Failed-Challenges to Developing Vaccines Against Immunoregulating Pathogens.
    Li S; Plebanski M; Smooker P; Gowans EJ
    Front Microbiol; 2015; 6():1318. PubMed ID: 26640461
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome-based vaccine design: the promise for malaria and other infectious diseases.
    Doolan DL; Apte SH; Proietti C
    Int J Parasitol; 2014 Oct; 44(12):901-13. PubMed ID: 25196370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Achievements and perspectives of research into development of a vaccine against malaria].
    Wiśniewski M; Zak DJ
    Wiad Parazytol; 2010; 56(2):133-40. PubMed ID: 20707297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of safety data reporting in clinical trials of vaccines against malaria, tuberculosis, and human immunodeficiency virus.
    Tamminga C; Kavanaugh M; Fedders C; Maiolatesi S; Abraham N; Bonhoeffer J; Heininger U; Vasquez CS; Moorthy VS; Epstein JE; Richie TL
    Vaccine; 2013 Aug; 31(35):3628-35. PubMed ID: 23395586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of combined HIV/HCV immunogens: a combined HIV-1/HCV candidate vaccine induces a higher level of CD8+ T cell-immune responses in HLA-A2.1 mice.
    Azizi A; Ghorbani M; Soare C; Mojibian M; Diaz-Mitoma F
    Curr HIV Res; 2007 Mar; 5(2):211-9. PubMed ID: 17346135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and strategies for developing efficacious and long-lasting malaria vaccines.
    Beeson JG; Kurtovic L; Dobaño C; Opi DH; Chan JA; Feng G; Good MF; Reiling L; Boyle MJ
    Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned.
    Kilpeläinen A; Maya-Hoyos M; Saubí N; Soto CY; Joseph Munne J
    Expert Rev Vaccines; 2018 Nov; 17(11):1005-1020. PubMed ID: 30300040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Established Immunoregulatory Networks on Vaccine Efficacy and the Development of Immunity to Malaria.
    Montes de Oca M; Good MF; McCarthy JS; Engwerda CR
    J Immunol; 2016 Dec; 197(12):4518-4526. PubMed ID: 27913644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria vaccine development: progress and challenges.
    Reed ZH; Friede M; Kieny MP
    Curr Mol Med; 2006 Mar; 6(2):231-45. PubMed ID: 16515513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.
    Folgori A; Capone S; Ruggeri L; Meola A; Sporeno E; Ercole BB; Pezzanera M; Tafi R; Arcuri M; Fattori E; Lahm A; Luzzago A; Vitelli A; Colloca S; Cortese R; Nicosia A
    Nat Med; 2006 Feb; 12(2):190-7. PubMed ID: 16462801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic Plasmodium that expresses HIV-1 Gag elicits immunity and protects mice against vaccinia virus-gag and malarial parasites.
    Jiang B; Qin L; Du Y; Peng N; Chen L; Chen Z; Chen X
    Vaccine; 2010 Nov; 28(50):7915-22. PubMed ID: 20933565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Vaccine Technologies.
    Loomis RJ; Johnson PR
    Vaccines (Basel); 2015 May; 3(2):429-47. PubMed ID: 26343196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C vaccines: Inducing and challenging memory T cells.
    Shiina M; Rehermann B
    Hepatology; 2006 Jun; 43(6):1395-8. PubMed ID: 16729320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing malaria vaccines to circumvent antigen variability.
    Ouattara A; Barry AE; Dutta S; Remarque EJ; Beeson JG; Plowe CV
    Vaccine; 2015 Dec; 33(52):7506-12. PubMed ID: 26475447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New challenges in modern vaccinology.
    Centlivre M; Combadière B
    BMC Immunol; 2015 Mar; 16():18. PubMed ID: 25879661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and challenges towards the development of malaria vaccines.
    Tetteh KK; Polley SD
    BioDrugs; 2007; 21(6):357-73. PubMed ID: 18020620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral vectors in malaria vaccine development.
    Limbach KJ; Richie TL
    Parasite Immunol; 2009 Sep; 31(9):501-19. PubMed ID: 19691555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Maternal immunity and mother-to-child transmission of HCV and HIV-1: challenges and recent advances].
    Ransy DG; Akouamba BS; Samson J; Lapointe N; Soudeyns H
    Med Sci (Paris); 2007 Nov; 23(11):991-6. PubMed ID: 18021713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.